Continuous intra-arterial blood glucose monitoring using quenched fluorescence sensing in intensive care patients after cardiac surgery: phase II of a product development study.

@article{Macken2015ContinuousIB,
  title={Continuous intra-arterial blood glucose monitoring using quenched fluorescence sensing in intensive care patients after cardiac surgery: phase II of a product development study.},
  author={Lewis Macken and Oliver J Flower and Simon D. Bird and N. E. B. Hammond and Elizabeth A Yarad and Frances Bass and Charles Marshall Fisher and Paul J. Strasma and Simon Finfer},
  journal={Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine},
  year={2015},
  volume={17 3},
  pages={
          190-6
        }
}
PURPOSE Variations in blood glucose (BG), hyperglycaemia and hypoglycaemia are associated with adverse clinical outcomes in intensive care unit patients. Continuous glucose monitoring (CGM) offers the potential to improve BG control, leading to improved patient outcomes. In our product development study, we determined the safety and performance of the GluCath Intravascular CGM System for up to 48 hours in 20 patients admitted to the ICU after cardiac surgery. METHODS The GluCath system uses a… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 12 REFERENCES

Continuous intra-arterial blood glucose monitoring using quenched fluorescence sensing: a product development study.

  • Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine
  • 2014

Glycaemic variability, infections and mortality in a medical-surgical intensive care unit.

  • Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine
  • 2014

Use of an intravascular fluorescent continuous glucose sensor in subjects with type 1 diabetes mellitus

M Romey, L Jovanovi, W Bevier
  • J Diabetes Sci Technol 2012;
  • 2012

Similar Papers

Loading similar papers…